BridgeMD
New treatment option for Fibromyalgia
Official title Augmentation of EMDR With tDCS in the Treatment of Fibromyalgia
ClinicalTrials.gov ID: NCT04084795
What this study is testing
- What it's testing
- Fibromyalgia (FM) is a generalized, widespread chronic pain disorder and has an estimated prevalence of 2%-4% in the general population. Current pharmacological and psychological interventions frequently produce limited benefits in FM patients.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70, women only
You may be able to join if
- Age between 18 and 70 years old
- Mean pain score of at least 4 on the visual analog scale (VAS) in the two weeks preceding the clinical trial
- Presence of one or more traumatic events causing current trauma-related symptoms
- Current clinical symptoms of depression and/or anxiety
- 2 weeks of stable medication
You likely can't join if
- Comorbid autoimmune or chronic inflammatory disease
- Neurological or serious medical diseases
- Bipolar disorder, schizoaffective disorder and schizophrenia
- Suicidal ideation
- Previous EMDR therapy in the past two years
- Substance abuse/dependency within 1 month prior to participation (except for nicotine abuse/dependency),
See the full eligibility criteria
- Age between 18 and 70 years old
- Mean pain score of at least 4 on the visual analog scale (VAS) in the two weeks preceding the clinical trial
- Presence of one or more traumatic events causing current trauma-related symptoms
- Current clinical symptoms of depression and/or anxiety
- 2 weeks of stable medication
- Comorbid autoimmune or chronic inflammatory disease
- Neurological or serious medical diseases
- Bipolar disorder, schizoaffective disorder and schizophrenia
- Suicidal ideation
- Previous EMDR therapy in the past two years
- Substance abuse/dependency within 1 month prior to participation (except for nicotine abuse/dependency),
- Pending FM-related litigation or disability
- Metallic implants in the head
- Positive test for pregnancy
- Skin sensitivity diseases (psoriasis, eczema, dermatitis, etc.)
The study team makes the final eligibility decision.
Where it's taking place
- Barcelona, Catalonia, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Barcelona, Catalonia, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.